{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:10:18Z","timestamp":1782979818015,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12975-023-01196-8","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T02:01:46Z","timestamp":1696298506000},"page":"1165-1175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Mesenchymal Stem Cells Overexpressing FGF21 Preserve Blood-Brain Barrier Integrity in Experimental Ischemic Stroke"],"prefix":"10.1007","volume":"15","author":[{"given":"Phuong Thao","family":"Do","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Maw","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Che","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Zong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo-Jhen","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hsiao","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaur-Jong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"issue":"8","key":"1196_CR1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153\u2013639.","journal-title":"Circulation."},{"issue":"5","key":"1196_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","volume":"18","author":"CO Johnson","year":"2019","unstructured":"Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439\u201358.","journal-title":"Lancet Neurol."},{"issue":"3","key":"1196_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","volume":"1","author":"Y Persidsky","year":"2006","unstructured":"Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood\u2013brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol. 2006;1(3):223\u201336.","journal-title":"J Neuroimmune Pharmacol."},{"issue":"4","key":"1196_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","volume":"27","author":"Y Yang","year":"2007","unstructured":"Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27(4):697\u2013709.","journal-title":"J Cereb Blood Flow Metab."},{"issue":"1","key":"1196_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0643-x","volume":"8","author":"A Nagpal","year":"2017","unstructured":"Nagpal A, Choy FC, Howell S, Hillier S, Chan F, Hamilton-Bruce MA, et al. Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis. Stem Cell Res Ther. 2017;8(1):1\u201313.","journal-title":"Stem Cell Res Ther."},{"key":"1196_CR6","doi-asserted-by":"crossref","unstructured":"Li Z, Dong X, Tian M, Liu C, Wang K, Li L, et al. Stem cell-based therapies for ischemic stroke: a systematic review and meta-analysis of clinical trials. Stem Cell Res Ther 2020;11(1):1-13.","DOI":"10.1186\/s13287-020-01762-z"},{"issue":"10","key":"1196_CR7","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/dmcn.13528","volume":"59","author":"N Wagenaar","year":"2017","unstructured":"Wagenaar N, Nijboer CH, van Bel F. Repair of neonatal brain injury: bringing stem cell-based therapy into clinical practice. Dev Med Child Neurol. 2017;59(10):997\u20131003.","journal-title":"Dev Med Child Neurol."},{"issue":"5","key":"1196_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.molmed.2012.02.003","volume":"18","author":"O Honmou","year":"2012","unstructured":"Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD. Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol Med. 2012;18(5):292\u20137.","journal-title":"Trends Mol Med"},{"issue":"1","key":"1196_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","volume":"16","author":"P Ballabh","year":"2004","unstructured":"Ballabh P, Braun A, Nedergaard M. The blood\u2013brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16(1):1\u201313.","journal-title":"Neurobiol Dis."},{"key":"1196_CR10","volume-title":"Seminars in cell & developmental biology","author":"RF Haseloff","year":"2015","unstructured":"Haseloff RF, Dithmer S, Winkler L, Wolburg H, Blasig IE. Transmembrane proteins of the tight junctions at the blood\u2013brain barrier: structural and functional aspects. In: Seminars in cell & developmental biology. Elsevier; 2015."},{"issue":"1","key":"1196_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0180-4","volume":"6","author":"HJ Park","year":"2015","unstructured":"Park HJ, Shin JY, Kim HN, Oh SH, Song SK, Lee PH. Mesenchymal stem cells stabilize the blood\u2013brain barrier through regulation of astrocytes. Stem Cell Res Ther. 2015;6(1):1\u201312.","journal-title":"Stem Cell Res Ther."},{"issue":"10","key":"1196_CR12","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/sj.jcbfm.9600475","volume":"27","author":"A Zacharek","year":"2007","unstructured":"Zacharek A, Chen J, Li A, Cui X, Li Y, Roberts C, et al. Angiopoietin1\/Tie2 and VEGF\/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab. 2007;27(10):1684\u201391.","journal-title":"J Cereb Blood Flow Metab."},{"key":"1196_CR13","volume-title":"Kimura T, et al","author":"A Kikuchi-Taura","year":"2021","unstructured":"Kikuchi-Taura A, Okinaka Y, Saino O, Takeuchi Y, Ogawa Y. Kimura T, et al. Stem Cells: Gap junction-mediated cell-cell interaction between transplanted mesenchymal stem cells and vascular endothelium in stroke; 2021."},{"issue":"9","key":"1196_CR14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/glia.20515","volume":"55","author":"X Fu","year":"2007","unstructured":"Fu X, Li Q, Feng Z, Mu D. The roles of aquaporin-4 in brain edema following neonatal hypoxia ischemia and reoxygenation in a cultured rat astrocyte model. Glia. 2007;55(9):935\u201341.","journal-title":"Glia."},{"issue":"2","key":"1196_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/72256","volume":"6","author":"GT Manley","year":"2000","unstructured":"Manley GT, Fujimura M, Ma T, Noshita N, Filiz F, Bollen AW, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med. 2000;6(2):159\u201363.","journal-title":"Nat Med."},{"issue":"12","key":"1196_CR16","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1002\/stem.1808","volume":"32","author":"G Tang","year":"2014","unstructured":"Tang G, Liu Y, Zhang Z, Lu Y, Wang Y, Huang J, et al. Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia. Stem Cells. 2014;32(12):3150\u201362.","journal-title":"Stem Cells."},{"key":"1196_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fphys.2019.00419","volume":"10","author":"C Tezze","year":"2019","unstructured":"Tezze C, Romanello V, Sandri M. FGF21 as modulator of metabolism in health and disease. Front Physiol. 2019;10:419.","journal-title":"Front Physiol."},{"issue":"12","key":"1196_CR18","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1161\/STROKEAHA.118.022119","volume":"49","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Liu N, Wang Q, Yu Z, Lin L, Yuan J, et al. Endocrine regulator rFGF21 improves neurological outcomes following focal ischemic stroke of type 2 diabetes male mice. Stroke. 2018;49(12):3039.","journal-title":"Stroke."},{"issue":"1","key":"1196_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01921-2","volume":"17","author":"D Wang","year":"2020","unstructured":"Wang D, Liu F, Zhu L, Lin P, Han F, Wang X, et al. FGF21 alleviates neuroinflammation following ischemic stroke by modulating the temporal and spatial dynamics of microglia\/macrophages. J Neuroinflammation. 2020;17(1):1\u201317.","journal-title":"J Neuroinflammation."},{"issue":"1","key":"1196_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"Z Wang","year":"2016","unstructured":"Wang Z, Leng Y, Wang J, Liao H-M, Bergman J, Leeds P, et al. Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of \u03b1-tubulin acetylation and FGF-21 up-regulation. Sci Rep. 2016;6(1):1\u201312.","journal-title":"Sci Rep."},{"issue":"3","key":"1196_CR21","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/ijms21030824","volume":"21","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Lin L, Liu N, Wang Q, Yuan J, Li Y, et al. FGF21 protects against aggravated blood-brain barrier disruption after ischemic focal stroke in diabetic db\/db male mice via cerebrovascular PPAR\u03b3 activation. Int J Mol Sci. 2020;21(3):824.","journal-title":"Int J Mol Sci."},{"key":"1196_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fphar.2019.00101","volume":"10","author":"H-W Wang","year":"2019","unstructured":"Wang H-W, Jiang X, Zhang Y, Wang J, Xie J, Wang Y-Q, et al. FGF21 protects against hypoxia injury through inducing HSP72 in cerebral microvascular endothelial cells. Front Pharmacol. 2019;10:101.","journal-title":"Front Pharmacol."},{"issue":"6","key":"1196_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tem.2014.03.001","volume":"25","author":"RE Gimeno","year":"2014","unstructured":"Gimeno RE, Moller DE. FGF21-based pharmacotherapy\u2013potential utility for metabolic disorders. Trends Endocrinol Metab. 2014;25(6):303\u201311.","journal-title":"Trends Endocrinol Metab."},{"issue":"1","key":"1196_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/neu.2019.6422","volume":"37","author":"RA Shahror","year":"2020","unstructured":"Shahror RA, Linares GR, Wang Y, Hsueh S-C, Wu C-C, Chuang D-M, et al. Transplantation of mesenchymal stem cells overexpressing fibroblast growth factor 21 facilitates cognitive recovery and enhances neurogenesis in a mouse model of traumatic brain injury. J Neurotrauma. 2020;37(1):14\u201326.","journal-title":"J Neurotrauma."},{"issue":"10","key":"1196_CR25","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/cbin.11409","volume":"44","author":"GR Linares","year":"2020","unstructured":"Linares GR, Leng Y, Maric D, Chuang DM. Overexpression of fibroblast growth factor-21 (FGF-21) protects mesenchymal stem cells against caspase-dependent apoptosis induced by oxidative stress and inflammation. Cell Biol Int. 2020;44(10):2163\u20139.","journal-title":"Cell Biol Int."},{"issue":"11","key":"1196_CR26","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/ijms20112624","volume":"20","author":"RA Shahror","year":"2019","unstructured":"Shahror RA, Ali AAA, Wu C-C, Chiang Y-H, Chen K-Y. Enhanced homing of mesenchymal stem cells overexpressing fibroblast growth factor 21 to injury site in a mouse model of traumatic brain injury. Int J Mol Sci. 2019;20(11):2624.","journal-title":"Int J Mol Sci."},{"key":"1196_CR27","doi-asserted-by":"crossref","unstructured":"Li X, Hong Y, He H, Jiang G, You W, Liang X, et al. FGF21 mediates mesenchymal stem cell senescence via regulation of mitochondrial dynamics. Oxid Med Cell Longev. 2019;2019:4915149.","DOI":"10.1155\/2019\/4915149"},{"issue":"6","key":"1196_CR28","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/01.STR.13.6.855","volume":"13","author":"P Coyle","year":"1982","unstructured":"Coyle P. Middle cerebral artery occlusion in the young rat. Stroke. 1982;13(6):855\u20139.","journal-title":"Stroke."},{"issue":"8","key":"1196_CR29","doi-asserted-by":"publisher","first-page":"e0134920","DOI":"10.1371\/journal.pone.0134920","volume":"10","author":"SH Lee","year":"2015","unstructured":"Lee SH, Jin KS, Bang OY, Kim BJ, Park SJ, Lee NH, et al. Differential migration of mesenchymal stem cells to ischemic regions after middle cerebral artery occlusion in rats. PLoS One. 2015;10(8):e0134920.","journal-title":"PLoS One."},{"issue":"1","key":"1196_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"X-b Guo","year":"2017","unstructured":"Guo X-b, Deng X, Wei Y. Homing of cultured endothelial progenitor cells and their effect on traumatic brain injury in rat model. Sci Rep. 2017;7(1):1\u201310.","journal-title":"Sci Rep."},{"issue":"1","key":"1196_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/jcbfm.2010.195","volume":"31","author":"Z Wang","year":"2011","unstructured":"Wang Z, Leng Y, Tsai L-K, Leeds P, Chuang D-M. Valproic acid attenuates blood\u2013brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J Cereb Blood Flow Metab. 2011;31(1):52\u20137.","journal-title":"J Cereb Blood Flow Metab."},{"key":"1196_CR32","doi-asserted-by":"crossref","unstructured":"Zador Z, Stiver S, Wang V, Manley GT. Role of aquaporin-4 in cerebral edema and stroke. Aquaporins. 2009;(190):159\u201370.","DOI":"10.1007\/978-3-540-79885-9_7"},{"issue":"3","key":"1196_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12975-019-00736-5","volume":"11","author":"MM Lalu","year":"2020","unstructured":"Lalu MM, Montroy J, Dowlatshahi D, Hutton B, Juneau P, Wesch N, et al. From the lab to patients: a systematic review and meta-analysis of mesenchymal stem cell therapy for stroke. Transl Stroke Res. 2020;11(3):345\u201364.","journal-title":"Transl Stroke Res."},{"key":"1196_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fneur.2019.00405","volume":"10","author":"N Satani","year":"2019","unstructured":"Satani N, Cai C, Giridhar K, McGhiey D, George S, Parsha K, et al. World-wide efficacy of bone marrow derived mesenchymal stromal cells in preclinical ischemic stroke models: systematic review and meta-analysis. Front Neurol. 2019;10:405.","journal-title":"Front Neurol."},{"issue":"1","key":"1196_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1153-1","volume":"15","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, Wang L, Qu M, Liang H, Li W, Li Y, et al. Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice. J Neuroinflammation. 2018;15(1):1\u201311.","journal-title":"J Neuroinflammation."},{"key":"1196_CR36","doi-asserted-by":"publisher","first-page":"096368972110241","DOI":"10.1177\/09636897211024183","volume":"30","author":"Y Yoshida","year":"2021","unstructured":"Yoshida Y, Takagi T, Kuramoto Y, Tatebayashi K, Shirakawa M, Yamahara K, et al. Intravenous administration of human amniotic mesenchymal stem cells in the subacute phase of cerebral infarction in a mouse model ameliorates neurological disturbance by suppressing blood brain barrier disruption and apoptosis via immunomodulation. Cell Transplant. 2021;30:09636897211024183.","journal-title":"Cell Transplant."},{"key":"1196_CR37","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.12659\/MSM.907096","volume":"24","author":"L Chi","year":"2018","unstructured":"Chi L, Huang Y, Mao Y, Wu K, Zhang L, Nan G. Tail vein infusion of adipose-derived mesenchymal stem cell alleviated inflammatory response and improved blood brain barrier condition by suppressing endoplasmic reticulum stress in a middle cerebral artery occlusion rat model. Med Sci Monit: Int Medi J Exp Clin Res. 2018;24:3946.","journal-title":"Med Sci Monit: Int Medi J Exp Clin Res."},{"issue":"10","key":"1196_CR38","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1161\/STROKEAHA.110.612788","volume":"42","author":"L-K Tsai","year":"2011","unstructured":"Tsai L-K, Wang Z, Munasinghe J, Leng Y, Leeds P, Chuang D-M. Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. Stroke. 2011;42(10):2932\u20139.","journal-title":"Stroke."},{"issue":"6","key":"1196_CR39","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1007\/s12035-017-0663-7","volume":"55","author":"Q Wang","year":"2018","unstructured":"Wang Q, Yuan J, Yu Z, Lin L, Jiang Y, Cao Z, et al. FGF21 attenuates high-fat diet-induced cognitive impairment via metabolic regulation and anti-inflammation of obese mice. Mol Neurobiol. 2018;55(6):4702\u201317.","journal-title":"Mol Neurobiol."},{"issue":"17","key":"1196_CR40","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1089\/neu.2017.5271","volume":"35","author":"J Chen","year":"2018","unstructured":"Chen J, Hu J, Liu H, Xiong Y, Zou Y, Huang W, et al. FGF21 protects the blood\u2013brain barrier by upregulating PPAR\u03b3 via FGFR1\/\u03b2-klotho after traumatic brain injury. J Neurotrauma. 2018;35(17):2091\u2013103.","journal-title":"J Neurotrauma."},{"issue":"18","key":"1196_CR41","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.3390\/ijms221810045","volume":"22","author":"PT Do","year":"2021","unstructured":"Do PT, Wu C-C, Chiang Y-H, Hu C-J, Chen K-Y. Mesenchymal stem\/stromal cell therapy in blood\u2013brain barrier preservation following ischemia: molecular mechanisms and prospects. Int J Mol Sci. 2021;22(18):10045.","journal-title":"Int J Mol Sci."},{"issue":"11","key":"1196_CR42","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","volume":"42","author":"Y Yang","year":"2011","unstructured":"Yang Y, Rosenberg GA. Blood\u2013brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42(11):3323\u20138.","journal-title":"Stroke."},{"issue":"1","key":"1196_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1227\/01.NEU.0000097715.11966.8E","volume":"54","author":"EA Neuwelt","year":"2004","unstructured":"Neuwelt EA. Mechanisms of disease: the blood-brain barrier. Neurosurgery. 2004;54(1):131\u201342.","journal-title":"Neurosurgery."},{"issue":"9","key":"1196_CR44","first-page":"1016","volume":"15","author":"H Bauer","year":"2016","unstructured":"Bauer H, Traweger A. Tight junctions of the blood-brain barrier\u2013a molecular gatekeeper. CNS Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS Neurological Disorders). 2016;15(9):1016\u201329.","journal-title":"CNS Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS Neurological Disorders)."},{"issue":"1","key":"1196_CR45","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2741\/1915","volume":"11","author":"CJ Malemud","year":"2006","unstructured":"Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 2006;11(1):1696\u2013701.","journal-title":"Front Biosci."},{"issue":"2","key":"1196_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00726-010-0689-x","volume":"41","author":"T Klein","year":"2011","unstructured":"Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteases. Amino Acids. 2011;41(2):271\u201390.","journal-title":"Amino Acids."},{"key":"1196_CR47","first-page":"30","volume":"2015","author":"Y Yang","year":"1623","unstructured":"Yang Y, Rosenberg GA. Matrix metalloproteinases as therapeutic targets for stroke. Brain Res. 1623;2015:30\u20138.","journal-title":"Brain Res."},{"issue":"5","key":"1196_CR48","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1089\/ars.2011.3923","volume":"15","author":"C Lehner","year":"2011","unstructured":"Lehner C, Gehwolf R, Tempfer H, Krizbai I, Hennig B, Bauer H-C, et al. Oxidative stress and blood\u2013brain barrier dysfunction under particular consideration of matrix metalloproteinases. Antioxid Redox Signal. 2011;15(5):1305\u201323.","journal-title":"Antioxid Redox Signal."},{"issue":"1","key":"1196_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3171\/2010.6.JNS10207","volume":"114","author":"T Higashida","year":"2011","unstructured":"Higashida T, Kreipke CW, Rafols JA, Peng C, Schafer S, Schafer P, et al. The role of hypoxia-inducible factor-1\u03b1, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury. J Neurosurgery. 2011;114(1):92\u2013101.","journal-title":"J Neurosurgery."},{"key":"1196_CR50","doi-asserted-by":"crossref","unstructured":"Leng Y, Wang J, Wang Z, Liao H-M, Wei M, Leeds P, et al. Valproic acid and other HDAC inhibitors upregulate FGF21 gene expression and promote process elongation in glia by inhibiting HDAC2 and 3. International J Neuropsychopharmacology. 2016;19(8):pyw035.","DOI":"10.1093\/ijnp\/pyw035"},{"issue":"2","key":"1196_CR51","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5966\/sctm.2014-0103","volume":"4","author":"TN Chung","year":"2015","unstructured":"Chung TN, Kim JH, Choi BY, Chung SP, Kwon SW, Suh SW. Adipose-derived mesenchymal stem cells reduce neuronal death after transient global cerebral ischemia through prevention of blood-brain barrier disruption and endothelial damage. Stem Cells Transl Med. 2015;4(2):178\u201385.","journal-title":"Stem Cells Transl Med."}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-023-01196-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-023-01196-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-023-01196-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:17:02Z","timestamp":1730297822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-023-01196-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1007\/s12975-023-01196-8","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"5 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The research protocol of this study was approved by the Ethics Committee for the Care and Use of Laboratory Animals, Taipei Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}